---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-207645"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2022-08-01T23:59:59+00:00"
generated_at: "2026-06-24T06:39:49.752340+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD raises $15M from Rubric, extends debt maturity to Sept 2022

## Summary
- Issued 15,000 Series A Preferred ($1,000 stated value) and 565,000 common shares to Rubric for $15M gross proceeds.
- Rubric owns ~18.3% of common stock post-closing; Series A has $1,333/share liquidation preference and matures Dec 31, 2022.
- Financing Agreement with Sixth Street extended to Sept 30, 2022; can extend to Nov 30 if $7M additional equity raised.
- Sixth Street received warrants to buy up to 200,000 common shares at $0.01, plus 125,000 per monthly extension.
- Proceeds used for working capital and general corporate purposes; Board evaluating strategic alternatives.

## SEC filing metadata
- accession: 0001193125-22-207645
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2022-08-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000119312522207645/0001193125-22-207645-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000119312522207645/d356180d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-207645
- JSON: https://secwatch.observer/filing/0001193125-22-207645.json
- Plain text: https://secwatch.observer/filing/0001193125-22-207645.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.